Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method.

Drug design, development and therapy - 1 Jan 2023

Liu Xin, Ju Gehang, Yang Wenyu, Chen Lulu, Xu Nuo, He Qingfeng, Zhu Xiao, Ouyang Dongsheng

Abstract excerpt

Escitalopram (SCIT) represents a first-line antidepressant and antianxiety medication. Pharmacokinetic studies of SCIT have demonstrated considerable interindividual variability, emphasizing the need for personalized dosing. Accordingly, we aimed to create a repository of parametric population pharmacokinetic (PPK) models of SCIT to facilitate model-informed precision dosing. In November 2022, we searched PubMed,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kinetics

Share to Models, Biological

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 37789969
DOI: 10.2147/DDDT.S425654
PMCID: PMC10544162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method.PMID 37789969Read ↗

Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype.Semantic proximity Read ↗

Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients.Semantic proximity Read ↗

Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.Semantic proximity Read ↗

Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.Semantic proximity Read ↗

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically-Based Pharmacokinetic Modeling and Clinical Observation.Semantic proximity Read ↗

Estimation of CYP2D6*10 genotypes on citalopram disposition in Chinese subjects by population pharmacokinetic assay.Semantic proximity Read ↗

Escitalopram Adverse Events in Real-World Databases: Signal Detection, Prediction Modeling, and Network ToxicologySemantic proximity Read ↗

Utilizing Physiologically Based Pharmacokinetic Models to Support Rational Medication in Chinese Elderly PopulationSemantic proximity Read ↗

Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model Repository.Semantic proximity Read ↗

PharmGKB summary: citalopram pharmacokinetics pathway.Semantic proximity Read ↗

Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard Dosing.Semantic proximity Read ↗

Pharmacoepidemiology simulation study practices: A methodological reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.